{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:00:09Z","timestamp":1790470809996,"version":"4.1.0"},"reference-count":157,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008064","name":"Georgetown University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL-441015"],"award-info":[{"award-number":["HL-441015"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.heliyon.2023.e16951","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T12:57:23Z","timestamp":1685710643000},"page":"e16951","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Nanoparticle approaches for the renin-angiotensin system"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4063-1355","authenticated-orcid":false,"given":"Sajini D.","family":"Hettiarachchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9935-4866","authenticated-orcid":false,"given":"Young M.","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0067-2475","authenticated-orcid":false,"given":"Yadollah","family":"Omidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6434-2136","authenticated-orcid":false,"given":"Robert C.","family":"Speth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2023.e16951_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1748-1716.1898.tb00272.x","article-title":"Niere und kreislauf","volume":"8","author":"Tigerstedt","year":"1898","journal-title":"Scand. Arch. Physiol."},{"key":"10.1016\/j.heliyon.2023.e16951_bib8","series-title":"Reference Module in Biomedical Sciences","article-title":"Renin-angiotensin-aldosterone system","author":"Speth","year":"2021"},{"key":"10.1016\/j.heliyon.2023.e16951_bib9","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1681\/ASN.2016070734","article-title":"Physiology and pathophysiology of the intrarenal renin-angiotensin system: an update","volume":"28","author":"Yang","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.heliyon.2023.e16951_bib10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","article-title":"Counter-regulatory renin\u2013angiotensin system in cardiovascular disease","volume":"17","author":"Paz Ocaranza","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.heliyon.2023.e16951_bib11","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2174\/1389450117666160727142401","article-title":"The anti-inflammatory potential of ACE2\/angiotensin-(1-7)\/Mas receptor axis: evidence from basic and clinical research","volume":"18","author":"Rodrigues Prestes","year":"2017","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.heliyon.2023.e16951_bib12","article-title":"Peripheral levels of renin-angiotensin system components are associated with cognitive performance in huntington\u2019s disease","volume":"1358","author":"Rocha","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.heliyon.2023.e16951_bib13","doi-asserted-by":"crossref","first-page":"R244","DOI":"10.1152\/ajpregu.00323.2011","article-title":"Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice","volume":"302","author":"Yiannikouris","year":"2012","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.heliyon.2023.e16951_bib14","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.3201232","article-title":"Astrocytes synthesize angiotensinogen in brain","volume":"242","author":"Stornetta","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2023.e16951_bib15","series-title":"Reference Module in Biomedical Sciences","article-title":"Renin-angiotensin-aldosterone system","author":"Speth","year":"2021"},{"key":"10.1016\/j.heliyon.2023.e16951_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10286-018-0572-5","article-title":"The renin\u2013angiotensin system in cardiovascular autonomic control: recent developments and clinical implications","volume":"29","author":"Miller","year":"2019","journal-title":"Clin. Auton. Res."},{"key":"10.1016\/j.heliyon.2023.e16951_bib1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.carbpol.2016.01.047","article-title":"Antihypertensive nano-ceuticales based on chitosan biopolymer: physico-chemical evaluation and release kinetics","volume":"142","author":"Niaz","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.heliyon.2023.e16951_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11906-017-0720-7","article-title":"Blood pressure and the renal actions of AT 2 receptors","volume":"19","author":"Carey","year":"2017","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.heliyon.2023.e16951_bib18","doi-asserted-by":"crossref","first-page":"39721","DOI":"10.1074\/jbc.M105253200","article-title":"The angiotensin II AT2 receptor is an AT1receptor antagonist","volume":"276","author":"AbdAlla","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2023.e16951_bib19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/01.HYP.0000151622.47814.6f","article-title":"Renal angiotensin II type-2 receptors are upregulated and mediate the candesartan-induced natriuresis\/diuresis in obese Zucker rats","volume":"45","author":"Hakam","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.heliyon.2023.e16951_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/hr.2014.132","article-title":"Angiotensin AT2 receptor stimulation is anti-inflammatory in lipopolysaccharide-activated THP-1 macrophages via increased interleukin-10 production","volume":"38","author":"Dhande","year":"2015","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.heliyon.2023.e16951_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11010-019-03602-y","article-title":"Role of angiotensin type 2 receptor in improving lipid metabolism and preventing adiposity","volume":"461","author":"Nag","year":"2019","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.heliyon.2023.e16951_bib22","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/physrev.00036.2005","article-title":"Physiology of local renin-angiotensin systems","volume":"86","author":"Paul","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.heliyon.2023.e16951_bib23","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/nrc2945","article-title":"The renin\u2013angiotensin system and cancer: old dog, new tricks","volume":"10","author":"George","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.heliyon.2023.e16951_bib24","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.peptides.2011.02.008","article-title":"Local renin\u2013angiotensin system and the brain\u2014a continuous quest for knowledge","volume":"32","author":"Baltatu","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.heliyon.2023.e16951_bib25","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.heliyon.2023.e16951_bib26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2310\/6650.2007.00020","article-title":"Intracardiac and intrarenal renin-angiotensin systems: mechanisms of cardiovascular and renal effects","volume":"55","author":"Raizada","year":"2007","journal-title":"J. Invest. Med."},{"key":"10.1016\/j.heliyon.2023.e16951_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2023.e16951_bib28","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.heliyon.2023.e16951_bib29","article-title":"Escaping to nature during a pandemic: a natural experiment in asian cities during the COVID-19 pandemic with big social media data","volume":"3","author":"Lu","year":"2019","journal-title":"SocArXiv"},{"key":"10.1016\/j.heliyon.2023.e16951_bib30","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.heliyon.2023.e16951_bib31","series-title":"Pathophysiology and Pharmacotherapy of Cardiovascular Disease","first-page":"751","article-title":"Drugs targeting RAAS in the treatment of hypertension and other cardiovascular diseases","author":"Balakumar","year":"2015"},{"key":"10.1016\/j.heliyon.2023.e16951_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115466","article-title":"Decades-old renin inhibitors are still struggling to find a niche in antihypertensive therapy. A fleeting look at the old and the promising new molecules","volume":"28","author":"Ramya","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.heliyon.2023.e16951_bib33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/HYPERTENSIONAHA.121.17049","article-title":"Blood-brain barrier crossing renin-angiotensin drugs and cognition in the elderly: a meta-analysis","volume":"78","author":"Ho","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.heliyon.2023.e16951_bib34","doi-asserted-by":"crossref","first-page":"822","DOI":"10.3390\/pharmaceutics13060822","article-title":"Nanoparticle-mediated angiotensin-(1-9) drug delivery for the treatment of cardiac hypertrophy","volume":"13","author":"Sep\u00falveda-Rivas","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.heliyon.2023.e16951_bib35","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.fct.2015.08.005","article-title":"Silver and titanium dioxide nanoparticles alter oxidative\/inflammatory response and renin\u2013angiotensin system in brain","volume":"85","author":"Krawczy\u0144ska","year":"2015","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.heliyon.2023.e16951_bib2","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.7150\/thno.53644","article-title":"Dual-ligand supramolecular nanofibers inspired by the renin-angiotensin system for the targeting and synergistic therapy of myocardial infarction","volume":"11","author":"Wen","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.heliyon.2023.e16951_bib5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jmmm.2014.10.089","article-title":"Magnetic poly (d, l-lactide) nanoparticles loaded with aliskiren: a promising tool for hypertension treatment","volume":"380","author":"Antal","year":"2015","journal-title":"J. Magn. Magn Mater."},{"key":"10.1016\/j.heliyon.2023.e16951_bib36","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/1753944710384430","article-title":"Renin-angiotensin-aldosterone system blockade in high-risk hypertensive patients: current approaches and future trends","volume":"4","author":"Gullapalli","year":"2010","journal-title":"Therapeut. Adv. Cardiovascul. Disease"},{"key":"10.1016\/j.heliyon.2023.e16951_bib37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1592\/phco.29.2.193","article-title":"Aliskiren: an oral direct renin inhibitor for the treatment of hypertension","volume":"29","author":"Sanoski","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.heliyon.2023.e16951_bib38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/01.hjh.0000202812.72341.99","article-title":"Renin inhibition with aliskiren: where are we now, and where are we going?","volume":"24","author":"Azizi","year":"2006","journal-title":"J. Hypertens."},{"key":"10.1016\/j.heliyon.2023.e16951_bib39","doi-asserted-by":"crossref","first-page":"169S","DOI":"10.1378\/chest.129.1_suppl.169S","article-title":"Angiotensin-converting enzyme inhibitor-induced cough: ACCP evidence-based clinical practice guidelines","volume":"129","author":"Dicpinigaitis","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.heliyon.2023.e16951_bib40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2147\/VHRM.S15541","article-title":"A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors","author":"Siragy","year":"2011","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.heliyon.2023.e16951_bib41","first-page":"321","article-title":"Aldosterone receptor antagonists: current perspectives and therapies","author":"Guichard","year":"2013","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.heliyon.2023.e16951_bib42","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/CIRCULATIONAHA.109.895235","article-title":"Aldosterone receptor antagonists: effective but often forgotten","volume":"121","author":"Maron","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.heliyon.2023.e16951_bib43","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.bbcan.2019.04.006","article-title":"Nanoparticle-mediated targeted drug delivery for breast cancer treatment","volume":"1871","author":"Liyanage","year":"2019","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.heliyon.2023.e16951_bib44","doi-asserted-by":"crossref","first-page":"e0902","DOI":"10.5424\/sjar\/2016141-8205","article-title":"Nano chitosan-NPK fertilizer enhances the growth and productivity of wheat plants grown in sandy soil","volume":"14","author":"Abdel-Aziz","year":"2016","journal-title":"Spanish J. Agric. Res."},{"key":"10.1016\/j.heliyon.2023.e16951_bib45","series-title":"Recent Advances on Surface Engineering of Magnetic Iron Oxide Nanoparticles and Their Biomedical Applications","author":"Gupta","year":"2007"},{"key":"10.1016\/j.heliyon.2023.e16951_bib46","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1039\/C8NR08970A","article-title":"Triple conjugated carbon dots as a nano-drug delivery model for glioblastoma brain tumors","volume":"11","author":"Hettiarachchi","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.heliyon.2023.e16951_bib47","first-page":"698","article-title":"Effect of GPE-AGT nanoparticle shRNA transfection system mediated RNAi on early atherosclerotic lesion","volume":"5","author":"Lu","year":"2012","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.heliyon.2023.e16951_bib48","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.clpt.6100400","article-title":"Nanoparticles in medicine: therapeutic applications and developments","volume":"83","author":"Zhang","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.heliyon.2023.e16951_bib49","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.msec.2017.06.004","article-title":"Polymeric nanoparticles: a study on the preparation variables and characterization methods","volume":"80","author":"Crucho","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.heliyon.2023.e16951_bib50","doi-asserted-by":"crossref","first-page":"7030","DOI":"10.1039\/D1TB00628B","article-title":"Polysaccharide nanoparticles: from fabrication to applications","volume":"9","author":"Plucinski","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.heliyon.2023.e16951_bib51","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10311-017-0670-y","article-title":"Chitosan nanoparticles preparation and applications","volume":"16","author":"Divya","year":"2018","journal-title":"Environ. Chem. Lett."},{"key":"10.1016\/j.heliyon.2023.e16951_bib52","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijbiomac.2014.01.045","article-title":"Structural differences between chitin and chitosan extracted from three different marine sources","volume":"65","author":"Hajji","year":"2014","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.heliyon.2023.e16951_bib53","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1179\/143307509X440631","article-title":"Enzymatic degradation study of porous chitosan membrane","volume":"13","author":"Zainol","year":"2009","journal-title":"Mater. Res. Innovat."},{"key":"10.1016\/j.heliyon.2023.e16951_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jiec.2015.10.028","article-title":"Application of chitosan and chitosan derivatives as biomaterials","volume":"33","author":"Choi","year":"2016","journal-title":"J. Ind. Eng. Chem."},{"key":"10.1016\/j.heliyon.2023.e16951_bib55","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2174\/1389450121666200711172536","article-title":"Chitosan nanoparticles as a novel drug delivery system: a review article","volume":"21","author":"Matalqah","year":"2020","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.heliyon.2023.e16951_bib56","doi-asserted-by":"crossref","first-page":"269","DOI":"10.15171\/bi.2017.32","article-title":"Stimuli-responsive chitosan-based nanocarriers for cancer therapy","volume":"7","author":"Fathi","year":"2017","journal-title":"Bioimpacts: BI"},{"key":"10.1016\/j.heliyon.2023.e16951_bib57","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/med.21506","article-title":"Chitosan\u2010based multifunctional nanomedicines and theranostics for targeted therapy of cancer","volume":"38","author":"Fathi","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.heliyon.2023.e16951_bib58","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.ijbiomac.2019.10.272","article-title":"Methotrexate-conjugated chitosan-grafted pH-and thermo-responsive magnetic nanoparticles for targeted therapy of ovarian cancer","volume":"154","author":"Fathi","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.heliyon.2023.e16951_bib59","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijbiomac.2020.04.274","article-title":"Synthesis and characterization of timolol maleate-loaded quaternized chitosan-based thermosensitive hydrogel: a transparent topical ocular delivery system for the treatment of glaucoma","volume":"159","author":"Pakzad","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.heliyon.2023.e16951_bib60","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.microc.2009.02.001","article-title":"The effect of the molecular weight of chitosan nanoparticles and its application on drug delivery","volume":"92","author":"Yang","year":"2009","journal-title":"Microchem. J."},{"key":"10.1016\/j.heliyon.2023.e16951_bib61","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.radphyschem.2013.04.007","article-title":"The effect of degree of deacetylation on the radiation induced degradation of chitosan","volume":"94","author":"Ta\u015fk\u0131n","year":"2014","journal-title":"Radiat. Phys. Chem."},{"key":"10.1016\/j.heliyon.2023.e16951_bib62","first-page":"29193","article-title":"RBD and ACE2 embedded chitosan nanoparticles as a prevention approach for SARS-COV 2","volume":"37","author":"Orkhan","year":"2021","journal-title":"Biomed. J. Sci. Techn. Res."},{"key":"10.1016\/j.heliyon.2023.e16951_bib63","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.3390\/ijms19061717","article-title":"Protein polymer-based nanoparticles: fabrication and medical applications","volume":"19","author":"DeFrates","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2023.e16951_bib64","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijpharm.2017.01.067","article-title":"Protein-based nanoparticles: from preparation to encapsulation of active molecules","volume":"522","author":"Tarhini","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.heliyon.2023.e16951_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119289","article-title":"Protein-based nanoparticles for drug delivery purposes","volume":"581","author":"Mart\u00ednez-L\u00f3pez","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.heliyon.2023.e16951_bib66","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1080\/10717544.2021.1938756","article-title":"PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application","volume":"28","author":"Su","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.heliyon.2023.e16951_bib67","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3390\/jfb12040058","article-title":"Polyamide\/poly (amino acid) polymers for drug delivery","volume":"12","author":"Boddu","year":"2021","journal-title":"J. Funct. Biomater."},{"key":"10.1016\/j.heliyon.2023.e16951_bib68","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1039\/C7RA12826F","article-title":"Controlling nanodomain morphology of epoxy thermosets templated by poly (caprolactone)-block-poly (dimethylsiloxane)-block-poly (caprolactone) ABA triblock copolymer","volume":"8","author":"Yang","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.heliyon.2023.e16951_bib69","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1002\/jbm.a.36477","article-title":"Biodegradable polyanhydride\u2010based nanomedicines for blood to brain drug delivery","volume":"106","author":"Brenza","year":"2018","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.heliyon.2023.e16951_bib70","doi-asserted-by":"crossref","first-page":"13699","DOI":"10.1002\/anie.201306391","article-title":"Du W. Synthesis of highly pH-responsive glucose poly (orthoester)","volume":"52","author":"Li","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.heliyon.2023.e16951_bib71","article-title":"Polyphosphazene polymers: the next generation of biomaterials for regenerative engineering and therapeutic drug delivery","volume":"38","author":"Ogueri","year":"2020","journal-title":"J. Vacuum Sci. Tech. B, Nanotech. Microelect.: Materials, Processing, Measurem. Phenomena"},{"key":"10.1016\/j.heliyon.2023.e16951_bib72","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1163\/156856208786140382","article-title":"Synthesis and colon-specific drug delivery of a poly (acrylic acid-co-acrylamide)\/MBA nanosized hydrogel","volume":"19","author":"Ray","year":"2008","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.heliyon.2023.e16951_bib73","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.heliyon.2023.e16951_bib74","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1039\/c2cs15344k","article-title":"Targeted polymeric therapeutic nanoparticles: design, development and clinical translation","volume":"41","author":"Kamaly","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.heliyon.2023.e16951_bib75","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1039\/c3tb20191k","article-title":"Polymeric theranostics: using polymer-based systems for simultaneous imaging and therapy","volume":"1","author":"Krasia-Christoforou","year":"2013","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.heliyon.2023.e16951_bib76","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.nantod.2011.02.003","article-title":"Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies","volume":"6","author":"Iversen","year":"2011","journal-title":"Nano Today"},{"key":"10.1016\/j.heliyon.2023.e16951_bib77","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1021\/acs.chemrev.5b00346","article-title":"Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release","volume":"116","author":"Kamaly","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.heliyon.2023.e16951_bib78","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3390\/polym12051105","article-title":"Systematic studies on surface erosion of photocrosslinked polyanhydride tablets and data correlation with release kinetic models","volume":"12","author":"Geraili","year":"2020","journal-title":"Polymers"},{"key":"10.1016\/j.heliyon.2023.e16951_bib79","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2012.10.015","article-title":"Mathematical modeling of drug delivery from autocatalytically degradable PLGA microspheres\u2014a review","volume":"165","author":"Versypt","year":"2013","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.heliyon.2023.e16951_bib80","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/cmdc.201402290","article-title":"Stimuli\u2010responsive polymeric nanoparticles for nanomedicine","volume":"10","author":"Crucho","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.heliyon.2023.e16951_bib81","series-title":"Nanotechnology and Functional Materials for Engineers","author":"Dahman","year":"2017"},{"key":"10.1016\/j.heliyon.2023.e16951_bib82","series-title":"Fabrication and Self-Assembly of Nanobiomaterials: Applications of Nanobiomaterials","author":"Grumezescu","year":"2016"},{"key":"10.1016\/j.heliyon.2023.e16951_bib83","series-title":"Functionalized Nanomaterials for the Management of Microbial Infection","first-page":"77","article-title":"Metal nanoparticles for microbial infection","author":"Mordorski","year":"2017"},{"key":"10.1016\/j.heliyon.2023.e16951_bib84","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.envpol.2008.10.002","article-title":"Chemical stability of metallic nanoparticles: a parameter controlling their potential cellular toxicity in vitro","volume":"157","author":"Auffan","year":"2009","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.heliyon.2023.e16951_bib85","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1039\/b712170a","article-title":"Biological applications of gold nanoparticles","volume":"37","author":"Sperling","year":"2008","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.heliyon.2023.e16951_bib86","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.addr.2008.03.016","article-title":"Gold nanoparticles in delivery applications","volume":"60","author":"Ghosh","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.heliyon.2023.e16951_bib87","first-page":"1","article-title":"Gold nanoparticles: promising nanomaterials for the diagnosis of cancer and HIV\/AIDS","volume":"2011","author":"Kumar","year":"2011","journal-title":"J. Nanomater."},{"key":"10.1016\/j.heliyon.2023.e16951_bib88","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1039\/b517131h","article-title":"Green chemistry and the health implications of nanoparticles","volume":"8","author":"Albrecht","year":"2006","journal-title":"Green Chem."},{"key":"10.1016\/j.heliyon.2023.e16951_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2021.113621","article-title":"A bio-inspired plasmonic nanosensor for angiotensin-converting enzyme through peptide-mediated assembly of gold nanoparticles","volume":"195","author":"Su","year":"2022","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.heliyon.2023.e16951_bib90","first-page":"1","article-title":"Silver nanoparticle ink technology: state of the art","volume":"9","author":"Rajan","year":"2016","journal-title":"Nanotechnol. Sci. Appl."},{"key":"10.1016\/j.heliyon.2023.e16951_bib91","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0079-6468(08)70024-9","article-title":"7 antimicrobial activity and action of silver","volume":"31","author":"Russell","year":"1994","journal-title":"Prog. Med. Chem."},{"key":"10.1016\/j.heliyon.2023.e16951_bib92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/696918","article-title":"Current development of silver nanoparticle preparation, investigation, and application in the field of medicine","volume":"2015","author":"Murphy","year":"2015","journal-title":"J. Nanomater."},{"key":"10.1016\/j.heliyon.2023.e16951_bib93","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11468-007-9031-1","article-title":"Review of some interesting surface plasmon resonance-enhanced properties of noble metal nanoparticles and their applications to biosystems","volume":"2","author":"Jain","year":"2007","journal-title":"Plasmonics"},{"key":"10.1016\/j.heliyon.2023.e16951_bib94","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.matchemphys.2004.04.026","article-title":"Size and shape dependent melting temperature of metallic nanoparticles","volume":"88","author":"Qi","year":"2004","journal-title":"Mater. Chem. Phys."},{"key":"10.1016\/j.heliyon.2023.e16951_bib95","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/jat.2758","article-title":"Time\u2010dependent biodistribution and excretion of silver nanoparticles in male Wistar rats","volume":"32","author":"Dziendzikowska","year":"2012","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.heliyon.2023.e16951_bib96","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.compscitech.2005.10.003","article-title":"Mechanical characterization of nanofibers\u2013a review","volume":"66","author":"Tan","year":"2006","journal-title":"Compos. Sci. Technol."},{"key":"10.1016\/j.heliyon.2023.e16951_bib97","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/nano.2006.1.1.15","article-title":"Nanofibers and their applications in tissue engineering","volume":"1","author":"Vasita","year":"2006","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.heliyon.2023.e16951_bib98","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.1099074","article-title":"Spinning continuous fibers for nanotechnology","volume":"304","author":"Dzenis","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.heliyon.2023.e16951_bib99","doi-asserted-by":"crossref","DOI":"10.1103\/PhysRevLett.90.144502","article-title":"Controlling the fiber diameter during electrospinning","volume":"90","author":"Fridrikh","year":"2003","journal-title":"Phys. Rev. Lett."},{"key":"10.1016\/j.heliyon.2023.e16951_bib100","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1063\/1.1592638","article-title":"Fabrication of oriented polymeric nanofibers on planar surfaces by electrospinning","volume":"83","author":"Kameoka","year":"2003","journal-title":"Appl. Phys. Lett."},{"key":"10.1016\/j.heliyon.2023.e16951_bib101","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1016\/S0142-9612(02)00087-X","article-title":"Enhanced functions of osteoblasts on nanometer diameter carbon fibers","volume":"23","author":"Elias","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.heliyon.2023.e16951_bib102","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.hjh.0000410246.59221.b1","article-title":"Mortality patterns in hypertension","volume":"29","author":"Arima","year":"2011","journal-title":"J. Hypertens."},{"key":"10.1016\/j.heliyon.2023.e16951_bib103","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/HYPERTENSIONAHA.121.18192","article-title":"Hypertension pharmacological treatment in adults: a World Health Organization guideline executive summary","volume":"79","author":"Al-Makki","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.heliyon.2023.e16951_bib104","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0140-6736(03)13302-8","article-title":"Essential hypertension","volume":"361","author":"Staessen","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2023.e16951_bib105","first-page":"44","article-title":"The SPRINT research. A randomized trial of intensive versus standard blood-pressure control","volume":"62","author":"Widimsk\u00fd","year":"2016","journal-title":"Vnitr. Lek."},{"key":"10.1016\/j.heliyon.2023.e16951_bib106","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1751-7176.2011.00513.x","article-title":"Calcium channel blockers","volume":"13","author":"Elliott","year":"2011","journal-title":"J. Clin. Hypertens."},{"key":"10.1016\/j.heliyon.2023.e16951_bib107","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1093\/ajh\/hpw030","article-title":"Diuretics for hypertension: a review and update","volume":"29","author":"Roush","year":"2016","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.heliyon.2023.e16951_bib108","first-page":"1","article-title":"Beta\u2010blockers and inhibitors of the renin\u2010angiotensin aldosterone system for chronic heart failure with preserved ejection fraction","volume":"6","author":"Martin","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.heliyon.2023.e16951_bib109","series-title":"StatPearls [Internet]","article-title":"Therapeutic uses of diuretic agents","author":"Arumugham","year":"2021"},{"key":"10.1016\/j.heliyon.2023.e16951_bib110","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/10408398.2012.664829","article-title":"Isolation and characterization of peptides with antihypertensive activity in foodstuffs","volume":"55","author":"Puchalska","year":"2015","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.heliyon.2023.e16951_bib111","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1124\/pr.112.007278","article-title":"A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists","volume":"65","author":"Michel","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.heliyon.2023.e16951_bib112","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1124\/dmd.106.013797","article-title":"Absorption, distribution, metabolism, and elimination of the direct renin inhibitor aliskiren in healthy volunteers","volume":"35","author":"Waldmeier","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.heliyon.2023.e16951_bib3","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.3390\/ijms17121977","article-title":"Enhanced and extended anti-hypertensive effect of VP5 nanoparticles","volume":"17","author":"Yu","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2023.e16951_bib113","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/ajh\/hps044","article-title":"Do the lactotripeptides isoleucine\u2013proline\u2013proline and valine\u2013proline\u2013proline reduce systolic blood pressure in European subjects? A meta-analysis of randomized controlled trials","volume":"26","author":"Cicero","year":"2013","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.heliyon.2023.e16951_bib114","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/hsc.13156","article-title":"Risk factors of deaths related to cardiovascular diseases in World Health Organization (WHO) member countries","volume":"30","author":"\u015eahin","year":"2022","journal-title":"Health Soc. Care Community"},{"key":"10.1016\/j.heliyon.2023.e16951_bib115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0140-6736(16)30677-8","article-title":"Acute myocardial infarction","volume":"389","author":"Reed","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.heliyon.2023.e16951_bib116","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics\u20142020 update: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.heliyon.2023.e16951_bib117","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.heliyon.2023.e16951_bib118","article-title":"Effects of sacubitril\/valsartan on life quality in chronic heart failure: a systematic review and meta-analysis of randomized controlled trials","volume":"9","author":"Song","year":"2022","journal-title":"Fronti. Cardiovascul. Med."},{"key":"10.1016\/j.heliyon.2023.e16951_bib119","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/angiotensin-(1\u20137)\/MAS axis of the renin-angiotensin system: focus on angiotensin-(1\u20137)","volume":"98","author":"Santos","year":"2017","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.heliyon.2023.e16951_bib4","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.3390\/molecules24152710","article-title":"Protective effects of nanoparticle-loaded aliskiren on cardiovascular system in spontaneously hypertensive rats","volume":"24","author":"Pechanova","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.heliyon.2023.e16951_bib120","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1161\/HYPERTENSIONAHA.122.19378","article-title":"Angiotensin receptor blockers are associated with a lower risk of progression from mild cognitive impairment to dementia","volume":"79","author":"Deng","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.heliyon.2023.e16951_bib121","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3233\/JAD-181035","article-title":"Contributions by the brain renin-angiotensin system to memory, cognition, and alzheimer's disease","volume":"67","author":"Wright","year":"2019","journal-title":"J. Alzheim. Dis. : JAD"},{"key":"10.1016\/j.heliyon.2023.e16951_bib122","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0891-0618(00)00112-5","article-title":"Distribution of angiotensin IV binding sites (AT4 receptor) in the human forebrain, midbrain and pons as visualised by in vitro receptor autoradiography","volume":"20","author":"Chai","year":"2000","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.heliyon.2023.e16951_bib123","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/S0022-3565(25)39499-1","article-title":"Central angiotensin IV binding sites: distribution and specificity in Guinea pig brain","volume":"266","author":"Miller-Wing","year":"1993","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.heliyon.2023.e16951_bib124","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/j.1471-4159.2004.02600.x","article-title":"Metabolism of angiotensin II is required for its in vivo effect on dopamine release in the striatum of the rat","volume":"90","author":"Stragier","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.heliyon.2023.e16951_bib125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/jpet.102.045492","article-title":"Structure-activity study of LVV-hemorphin-7: angiotensin AT4 receptor ligand and inhibitor of insulin-regulated aminopeptidase","volume":"305","author":"Lee","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.heliyon.2023.e16951_bib126","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00259-007-0699-4","article-title":"Acetylcholine esterase activity in mild cognitive impairment and Alzheimer\u2019s disease","volume":"35","author":"Herholz","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.heliyon.2023.e16951_bib127","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/brain\/awl269","article-title":"CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease","volume":"129","author":"Buerger","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.heliyon.2023.e16951_bib128","first-page":"203","article-title":"The immunopathogenic role of reactive oxygen species in Alzheimer disease","author":"Mohsenzadegan","year":"2012","journal-title":"Iran. J. Allergy, Asthma Immunol."},{"key":"10.1016\/j.heliyon.2023.e16951_bib129","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2019.10.034","article-title":"Nanoparticle-mediated approaches for Alzheimer\u2019s disease pathogenesis, diagnosis, and therapeutics","volume":"314","author":"Hettiarachchi","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.heliyon.2023.e16951_bib130","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","article-title":"Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing","volume":"51","author":"Kunkle","year":"2019","journal-title":"Nat. Genet."},{"key":"10.1016\/j.heliyon.2023.e16951_bib131","doi-asserted-by":"crossref","first-page":"eaaz2541","DOI":"10.1126\/scitranslmed.aaz2541","article-title":"A\u03b2-accelerated neurodegeneration caused by Alzheimer\u2019s-associated ACE variant R1279Q is rescued by angiotensin system inhibition in mice","volume":"12","author":"Cuddy","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.heliyon.2023.e16951_bib132","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s11357-020-00231-y","article-title":"Brain angiotensin II and angiotensin IV receptors as potential Alzheimer\u2019s disease therapeutic targets","volume":"42","author":"Royea","year":"2020","journal-title":"Geroscience"},{"key":"10.1016\/j.heliyon.2023.e16951_bib133","doi-asserted-by":"crossref","first-page":"5562","DOI":"10.1523\/JNEUROSCI.0329-17.2017","article-title":"Angiotensin IV receptors mediate the cognitive and cerebrovascular benefits of losartan in a mouse model of Alzheimer's disease","volume":"37","author":"Royea","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.heliyon.2023.e16951_bib134","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1474-4422(05)70141-1","article-title":"The age-dependent relation of blood pressure to cognitive function and dementia","volume":"4","author":"Qiu","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.heliyon.2023.e16951_bib135","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/joim.12838","article-title":"Connecting the brain cholesterol and renin\u2013angiotensin systems: potential role of statins and RAS\u2010modifying medications in dementia","volume":"284","author":"Petek","year":"2018","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.heliyon.2023.e16951_bib136","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3233\/JAD-171119","article-title":"The coming of age of the angiotensin hypothesis in Alzheimer\u2019s disease: progress toward disease prevention and treatment?","volume":"62","author":"Kehoe","year":"2018","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.heliyon.2023.e16951_bib6","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1021\/nn900813b","article-title":"Ultrasensitive and highly selective detection of Alzheimer\u2019s disease biomarker using two-photon Rayleigh scattering properties of gold nanoparticle","volume":"3","author":"Neely","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/j.heliyon.2023.e16951_bib137","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1021\/nn300489k","article-title":"PEGylated nanoparticles bind to and alter amyloid-beta peptide conformation: toward engineering of functional nanomedicines for Alzheimer\u2019s disease","volume":"6","author":"Brambilla","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.heliyon.2023.e16951_bib138","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/ana.410320306","article-title":"Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia","volume":"32","author":"Allen","year":"1992","journal-title":"Ann. Neurol.: Official J. Am. Neurol. Associat. Child Neurol. Society"},{"key":"10.1016\/j.heliyon.2023.e16951_bib139","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/mds.25614","article-title":"Dopamine\u2010angiotensin interactions in the basal ganglia and their relevance for Parkinson's disease","volume":"28","author":"Labandeira\u2010Garcia","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.heliyon.2023.e16951_bib140","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3389\/fendo.2013.00158","article-title":"A role for the brain RAS in Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"4","author":"Wright","year":"2013","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.heliyon.2023.e16951_bib141","first-page":"67","article-title":"Brain renin-angiotensin system and dopaminergic cell vulnerability","volume":"8","author":"Labandeira-Garc\u00eda","year":"2014","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.heliyon.2023.e16951_bib142","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2021.638519","article-title":"The renin\u2013angiotensin system modulates dopaminergic neurotransmission: a new player on the scene","volume":"13","author":"Kobiec","year":"2021","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.heliyon.2023.e16951_bib143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/152474","article-title":"Liposomal antioxidants for protection against oxidant-induced damage","volume":"2011","author":"Suntres","year":"2011","journal-title":"J. Toxicol."},{"key":"10.1016\/j.heliyon.2023.e16951_bib144","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s11064-010-0217-0","article-title":"Liposomal-glutathione provides maintenance of intracellular glutathione and neuroprotection in mesencephalic neuronal cells","volume":"35","author":"Zeevalk","year":"2010","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.heliyon.2023.e16951_bib145","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1002\/ana.410320714","article-title":"Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease","volume":"32","author":"Jenner","year":"1992","journal-title":"Ann. Neurol.: Offi. J. Am. Neurol. Associat. Child Neurol. Society"},{"key":"10.1016\/j.heliyon.2023.e16951_bib146","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"cell"},{"key":"10.1016\/j.heliyon.2023.e16951_bib147","doi-asserted-by":"crossref","first-page":"992","DOI":"10.3390\/ijms22030992","article-title":"Can SARS-CoV-2 virus use multiple receptors to enter host cells?","volume":"22","author":"Gadanec","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2023.e16951_bib148","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.heliyon.2023.e16951_bib149","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3389\/fimmu.2017.01960","article-title":"Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes?","volume":"8","author":"Fulop","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2023.e16951_bib150","doi-asserted-by":"crossref","first-page":"29274","DOI":"10.1073\/pnas.2009875117","article-title":"Targeting the renin\u2212 angiotensin signaling pathway in COVID-19: unanswered questions, opportunities, and challenges","volume":"117","author":"Sriram","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.heliyon.2023.e16951_bib151","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ddr.21672","article-title":"Response to recent commentaries regarding the involvement of angiotensin-converting enzyme 2 (ACE2) and renin-angiotensin system blockers in SARS-CoV-2 infections","volume":"81","author":"Speth","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.heliyon.2023.e16951_bib152","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taaa045","article-title":"Keep taking your ACE inhibitors and ARBs during the COVID 19 pandemic","volume":"27","author":"Speth","year":"2020","journal-title":"J. Trav. Med."},{"key":"10.1016\/j.heliyon.2023.e16951_bib153","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13054-020-03032-z","article-title":"Angiotensin II administration to COVID-19 patients is not advisable","volume":"24","author":"Speth","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.heliyon.2023.e16951_bib154","first-page":"1","article-title":"Renin\u2013angiotensin\u2013aldosterone system inhibitors in patients with covid-19","author":"Vaduganathan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heliyon.2023.e16951_bib155","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/cpt.1863","article-title":"Risks of ACE inhibitor and ARB usage in COVID\u201019: evaluating the evidence","volume":"108","author":"Sriram","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.heliyon.2023.e16951_bib156","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1111\/bph.15082","article-title":"A hypothesis for pathobiology and treatment of COVID\u201019: the centrality of ACE1\/ACE2 imbalance","volume":"177","author":"Sriram","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2023.e16951_bib157","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/ac1c22","article-title":"A nanotechnological approach in the current therapy of COVID-19: model drug oseltamivir-phosphate loaded PLGA nanoparticles targeted with spike protein binder peptide of SARS-CoV-2","volume":"32","author":"Ucar","year":"2021","journal-title":"Nanotechnology"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023041580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023041580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:33:55Z","timestamp":1790469235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023041580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":157,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2405844023041580"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16951","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticle approaches for the renin-angiotensin system","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16951","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e16951"}}